#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Longterm Efficiency of a Deep Sclerectomy with T-Flux Implant


Authors: P. Studený 1,2;  L. Koliášová 1;  D. Siveková 2;  J. Vránová 3;  P. Kuchynka 2
Authors place of work: Oční oddělení Karlovarské krajské nemocnice a. s., prim. MUDr. Andrej Farkaš 1;  Oční klinika FNKV a 3. LF UK, Praha, přednosta prof. MUDr. Pavel Kuchynka, CSc. 2;  Ústav lékařské biofyziky a lékařské informatiky, 3. LF UK, Praha, přednosta doc. MUDr. Jozef Rosina, Ph. D. 3
Published in the journal: Čes. a slov. Oftal., 67, 2011, No. 1, p. 7-11
Category: Original Article

Summary

Purpose:
To evaluate a longterm efficiencyt of a deep sclerectomy with T-Flux implant on intraocular pressure

Methods:
Retrospective noncomparative analysis of glaucomatic patiens from our ambulance who underwent deep sclerectomy combined with T-flux implantation. The main postoperative outcome measures were intraocular pressure (IOP), number of treatments and Nd:YAG goniopunctures.

Results:
Mean preoperative IOP was 26,7 (± 0,8) mmHg, mean postoperative IOP was 17,4 (± 0,8) at month 6, 16,5 (± 0,7) at month 12, 16,9 (± 0,9) at month 24, 17,2 (± 1,0) at month 36, 18,6 (± 1,1) at month 48, 17,6 (± 1,1) at month 60 and 18,3 (± 1,8) at month 72. Mean preoperative number of mediactions per patient was reduced from 2,5 (± 0,13) to 0,73 (± 0,13) at month 6,1,02 (± 0,13) at month 12, 1,1 (± 0,15) at month 24, 1,0 (± 0,18) at month 36, 1,22 (± 0,18) at month 48, 1,68 (± 0,2) at month 60, 1,8 (± 0,3) at month 72. Four patiens (10%) underwent early goniopuncture and six patiens (15%) late goniopuncture.

Conclusion:
Deep sclerectomy combined with T-Flux implant appears to be a relatively safe antiglaucomatic surgery with a minimum number of complications, high predictibility of the result and a very good long term effectivity.

Key words:
deep sclerectomy, T-Flux, goniopuncture


Zdroje

1. Ates, H., Uretmen, O., Andac, K. et al.: Deep sclerectomy with a nonabsorbable implant (T-Flux): preliminary results. Can J Ophthalmol, 38, 2003; 6: 482–8.

2. Auer, C., Mermoud, A., Herbort, C.P.: Deep sclerectomy for the management of uncontrolled uveitic glaucoma: prelimi­nary data. Klin Monatsbl Augenheilkd, 221, 2004; 5: 339–42.

3. Bissig, A., Rivier, D., Zaninetti, M. et al.: Ten years follow-up after deep sclere­ctomy with collagen implant. J Glaucoma, 17, 2008; 8: 680–6.

4. David, V.P., Kutty, K.G., Soma­sundra­ram, N. et al.: Five-year results of visco­ca­na­lostomy. Eur J Ophthalmol, 18, 2008; 3: 417–22.

5. Drolsum L.: Deep sclerectomy in patiens with capsular glaucoma. Acta Ophthalmol Scand, 81, 2003; 6: 567–72.

6. Drolsum L.: Conversion from trabecu­lectomy to deep sclerectomy. Prospective study of the first 44 cases. J Cataract Refract Surg, 29, 2003; 7: 1378–84.

7. Egrilmez, S., Ates, H., Nalcaci, S. et al.: Surgically induced corneal refractive change following glaucoma surgery: nonpenetrating trabecular surgeries versus trabeculectomy. J Cataract Refract Surg, 30, 2004; 6: 1232–9.

8. Fyodorov, S.N.: Non-penetrating deep sclerectomy in open-angle glaucoma. Eye Microsurg, 1989: 52–5.

9. Galassi, F., Giambene, B.: Deep scle­rectomy with SkGel implant: 5-years results. J Glaucoma, 17, 2008; 1: 52–6.

10. Hondur, A., Onol, M., Hasanreisoglu, B.: Nonpenetrating glaucoma surgery: meta-analysis of recent results. J Glaucoma, 17, 2008; 2: 139–46.

11. Chiou, A.G., Mermoud, A., Jewelewicz, D.A.: Post-operative inflammation follo­wing deep sclerectomy with collagen implant versus standard trabeculectomy. Graefes Arch Clin Exp Ophthalmol, 236, 1998; 8: 593–6..

12. Kozlov, V.I., Bagrov, S.N., Anisimova, S.Y. et al.: Deep sclerectomy with collagen. Eye Microsurg, 3, 1990: 44–46.

13. Krasnov, M.M.: Externalization of Schlemmęs canal (sinusotomy ) in glaucoma. Br J Ophthalmol, 52, 1968; 2: 157–61.

14. Mendrinos, E., Mermoud, A., Shaa­rawy, T.: Nonpe­netrating glaucoma sur­gery. Surv Ophthalmol, 53, 2008; 6: 592–630.

15. Mendrinos, E., Mansouri, K., Mermoud, A. et al.: Long-term results of deep sclerectomy with collagen implant in Exfoliative glaucoma. J Glaucoma,18, 2009; 5: 361–7.

16. Mermoud, A., Karlen, M.E., Schnyder, C.C. et al.: Nd:YAG goniopuncture after deep sclerectomy with collagen implant. Ophthalmic Surg Lasers., 30, 1999; 2: 120–5.

17. Mosaed, S., Dustin, L., Minckler, D.S.: Comparative outcomes between newer and older surgeries for glaucoma.Trans Am Ophthalmol Soc., 107, 2009; 127–33..

18. Mousa, A.S.: Preliminary evaluation of nonpenetrating deep sclerectomy with autologous scleral implant in open-angle glaucoma. Eye 21, 2007; 9: 1234–8.

19. Ravinet, E., Bovey, E., Mermoud, A.: T-flux implant versus Healon GV in deep sclerectomy. J Glaucoma, 13, 2004; 1: 46–50.

20. Russo, V., Scott, I.U., Stella, A., et al.: Nonpenetgrating deep sclerectomy with reticulated hyaluronic acid implant versus punch trabeculectomy: a prospective clinical trial. Eur J Ophthalmol, 18, 2008; 5: 751–7.

21. Shaarawy, T.: Postoperative manage­ment of non-penetrating filtering surgery. In: Mermoud, A., Shaarawy, T. (Eds), Non-Penetrating Glaucoma Surgery, London, Martin Dunitz Ltd, 2001, s.132–134.

22. Shaarawy, T.M., Sherwood, M.B., Grehn, F.: Guidelines on Design and Reporting of Glaucoma Surgical Trials. Amsterdam, Kugler Publications, 2009.

23. Wevill, M.T., Meyer, D., Van Aswegen, E.: A pilot study of deep sclerectomy with implantation of chromic suture material as a collagen implant: medium-term results. Eye, 19, 2005; 5: 549–54.

24. Wiermann, A., Zeits, O., Jochim, E., et al.: A comparison between absorbable and non-resorbable scleral implants in deep sclerectomy (T-Flux and SK-gel). Ophthalmologe, 104, 2007; 5: 409–14.

Štítky
Ophthalmology
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#